Clinical Trial Update: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of combining alpelisib with fulvestrant in Japanese men and postmenopausal women with advanced breast cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Alpelisib (alpelisib)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING